All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 36, Issue 4, Pages 498-507
Publisher
Oxford University Press (OUP)
Online
2015-03-06
DOI
10.1093/carcin/bgv018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer
- (2014) Mayuri Narvekar et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Effect of All-Trans Retinoic Acid on the Differentiation of U87 Glioma Stem/Progenitor Cells
- (2013) Zhe Shi et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Circulating IGF system and treatment outcome in epithelial ovarian cancer
- (2013) Yu-Fang Huang et al. ENDOCRINE-RELATED CANCER
- Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma
- (2013) Catarina Alisa Liebscher et al. HUMAN PATHOLOGY
- Differentiation therapy for solid tumors
- (2013) Wen Ping Xu et al. Journal of Digestive Diseases
- ALDH1-High Ovarian Cancer Stem-Like Cells Can Be Isolated from Serous and Clear Cell Adenocarcinoma Cells, and ALDH1 High Expression Is Associated with Poor Prognosis
- (2013) Takafumi Kuroda et al. PLoS One
- Prognostic Value of Cancer Stem Cell Marker Aldehyde Dehydrogenase in Ovarian Cancer: A Meta-Analysis
- (2013) Shuyan Liu et al. PLoS One
- Ovarian Cancer Stem Cells: A New Target for Cancer Therapy
- (2013) Qinglei Zhan et al. Biomed Research International
- ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome
- (2012) Yu-Chi Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures
- (2012) Yu-Ting Saw et al. BMC CANCER
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FoxM1 and Wnt/ -Catenin Signaling in Glioma Stem Cells
- (2012) A. Gong et al. CANCER RESEARCH
- All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway
- (2012) Young Chang Lim et al. EUROPEAN JOURNAL OF CANCER
- All-transretinoic acid in the treatment of pediatric acute promyelocytic leukemia
- (2012) Riccardo Masetti et al. Expert Review of Anticancer Therapy
- FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients
- (2012) Yu Wang et al. LUNG CANCER
- Overcoming Challenges of Ovarian Cancer Stem Cells: Novel Therapeutic Approaches
- (2012) Cristóbal Aguilar-Gallardo et al. Stem Cell Reviews and Reports
- Genome-Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy
- (2011) Shahab Uddin et al. AMERICAN JOURNAL OF PATHOLOGY
- Retinoids, Retinoic Acid Receptors, and Cancer
- (2011) Xiao-Han Tang et al. Annual Review of Pathology-Mechanisms of Disease
- Combination of paclitaxel- and retinoic acid-incorporated nanoparticles for the treatment of CT-26 colon carcinoma
- (2011) Gun-Young Hong et al. ARCHIVES OF PHARMACAL RESEARCH
- FOXM1: From cancer initiation to progression and treatment
- (2011) Chuay-Yeng Koo et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- γ-Secretase inhibitor, DAPT inhibits self-renewal and stemness maintenance of ovarian cancer stem-like cells in vitro
- (2011) Li-yu Jiang et al. Chinese Journal of Cancer Research
- The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells
- (2011) Jenny M. Whitworth et al. GYNECOLOGIC ONCOLOGY
- Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells
- (2011) Ilona Kryczek et al. INTERNATIONAL JOURNAL OF CANCER
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- ALDHhigh adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis
- (2010) Shuyang Sun et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling
- (2010) J. P. Sullivan et al. CANCER RESEARCH
- Induction of Human Epithelial Stem/Progenitor Expansion by FOXM1
- (2010) E. Gemenetzidis et al. CANCER RESEARCH
- High Aldehyde Dehydrogenase Activity Identifies Tumor-Initiating and Metastasis-Initiating Cells in Human Prostate Cancer
- (2010) Christel van den Hoogen et al. CANCER RESEARCH
- Retinoid signaling regulates breast cancer stem cell differentiation
- (2010) Christophe Ginestier et al. CELL CYCLE
- Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells
- (2010) B. Campos et al. CLINICAL CANCER RESEARCH
- Targeting Notch to Target Cancer Stem Cells
- (2010) A. Pannuti et al. CLINICAL CANCER RESEARCH
- Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells
- (2010) Zhiwei Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
- (2010) C. N. Landen et al. MOLECULAR CANCER THERAPEUTICS
- Foxm1 transcription factor is required for maintenance of pluripotency of P19 embryonal carcinoma cells
- (2010) Zhongqiu Xie et al. NUCLEIC ACIDS RESEARCH
- Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
- (2010) Shan Deng et al. PLoS One
- The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells
- (2010) Irene Ma et al. Stem Cell Reviews and Reports
- Aldehyde Dehydrogenase-Expressing Colon Stem Cells Contribute to Tumorigenesis in the Transition from Colitis to Cancer
- (2009) J. E. Carpentino et al. CANCER RESEARCH
- Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
- (2009) E. H. Huang et al. CANCER RESEARCH
- Forkhead box M1 transcription factor: A novel target for cancer therapy
- (2009) Zhiwei Wang et al. CANCER TREATMENT REVIEWS
- Ovarian Cancer
- (2008) Kathleen R. Cho et al. Annual Review of Pathology-Mechanisms of Disease
- Retinoic acid modulates retinaldehyde dehydrogenase 1 gene expression through the induction of GADD153–C/EBPβ interaction
- (2008) Guillermo Elizondo et al. BIOCHEMICAL PHARMACOLOGY
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now